Inovio stock price – Business Insider Australia

Markets Apr. 23, 2021, 4:58 PM

Inovio sinks 26% after US government decides to discontinue funding for next phase of COVID-19 vaccine trial

"The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines," said Inovio in a statement.

Markets Sep. 28, 2020, 10:53 PM

Inovio tanks 40% after pausing coronavirus vaccine trial, trading halted

Inovio Pharmaceuticals tumbled as much as 40% in early Monday trading after the biotech firm announced a temporary hold on its coronavirus vaccine’s phase 2/3 trial. The study is on “partial clinical hold” until questions asked by the Food and Drug Administration are answered, Inovio said in a press release. […]

Markets Aug. 11, 2020, 10:37 PM

Inovio Pharmaceuticals sheds 12% after earnings miss, update on its COVID-19 vaccine

Inovio Pharmaceuticals reported quarterly earnings results Monday that missed Wall Street’s expectations. Shares of the pharmaceutical company shed 12% in premarket trading Tuesday. The company also said its COVID-19 vaccine candidate will begin phase 2/3 clinical trials in the US in September, not over the summer as it had previously […]

Markets Jun. 30, 2020, 11:38 PM

Inovio’s 860% year-to-date rally takes a breather after the release of Phase I data for company’s COVID-19 vaccine candidate

Inovio has rallied 860% year-to-date as investors bid up the company’s stock in hopes of the successful development of a vaccine for COVID-19. On Tuesday, Inovio fell as much as 17.8% after the company released early Phase I data on its INO-4800 COVID-19 vaccine. The company said 94% of Phase […]

Markets Jan. 28, 2020, 4:36 AM

These 3 small pharmaceutical stocks are surging after announcing work on a coronavirus vaccine

Shares of Inovio Pharmaceuticals, Moderna Inc., and Novavax Inc. all surged Monday as China’s coronavirus spread further. On Thursday, the Coalition for Epidemic Preparedness Innovations announced that it will provide as much as $US11 million in funding to the three companies to develop new vaccines against the Wuhan strain. Here’s […]